跳至主要内容
临床试验/NCT03312140
NCT03312140已完成不适用

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

University Hospital Tuebingen0 个研究点目标入组 10 人开始时间: 2014年11月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
主要终点
Measurement of D9-Methyl-Choline Kinetic

研究概览

简要总结

Pilot study to investigate the effect of choline chloride in cystic fibrosis patients with liver steatosis by comparing their status before and after the intervention

详细描述

Within this single arm pilot study patients with cystic fibrosis and liver steatosis receive choline chloride (2x0.5 gram three times a day) as a food supply for 88 days. D9-choline metabolism is measured before and after the intervention phase. Hypothesis of the study is, that supplying choline augments the secretion of phosphatidyl choline and lipoprotein (VLDL) from the liver and therefore results in a measurable reduction of the triglyceride storage of the liver.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age > 18 years
  • Cystic fibrosis is verified
  • pancreatic insufficiency
  • Decline of plasma phosphatidylcholine and steatosis of the liver
  • informed consent is given

排除标准

  • cirrhosis of the liver
  • Hyperreactivity to choline containing food
  • allergic bronchopulmonary aspergillosis or other acute exacerbations of pulmonary infections
  • FEV1 < 40%
  • chronic alcohol consume
  • clinically relevant diseases (for example thyroid dysfunction, disturbance of lipid metabolism, renal diseases, significant left or right ventricular functional restriction) which will change the lipid metabolism of the liver
  • Implants or other reasons which make magnetic resonance examinations impossible

研究组 & 干预措施

Choline Chloride

Other

Patients receive choline chloride (1g Choline) three times a day for 12.6 weeks as a food supply

干预措施: Choline Chloride (Drug)

结局指标

主要结局

Measurement of D9-Methyl-Choline Kinetic

时间窗: 3 months

The substitution of choline as a food supplement will augment the phosphatidylcholine and lipoprotein (VLDL) secretion of the liver into the blood and will therefore result in a reduction of the triglyceride retention in the liver

次要结局

  • Lipid storage of the liver(3 months)
  • MMEF(3 months)
  • Augmentation of creatinine concentration within the calf muscle(3 months)
  • MEF25(3 months)
  • FVC(3 months)
  • FEV1(3 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验